Stephens & Co. Maintains Overweight on Humana, Lowers Price Target to $570
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel maintains an Overweight rating on Humana (NYSE:HUM) but lowers the price target from $575 to $570.
November 02, 2023 | 2:32 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Humana's price target has been lowered from $575 to $570 by Stephens & Co., though the Overweight rating is maintained.
The lowering of the price target by Stephens & Co. could potentially create a negative sentiment among investors, but the maintained Overweight rating indicates that the analyst still sees potential in the stock. Therefore, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100